መነሻ › አቴሮስክሌሮሲስ › North Carolina

በNorth Carolina ለአቴሮስክሌሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአቴሮስክሌሮሲስ የሚደረጉ 12 ጥናቶች በNorth Carolina ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በNorth Carolina ውስጥ ያሉ ከተሞች

Official study text (English)

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

UNC Heart & Vascular, Chapel Hill

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Care Access - Fayetteville, Fayetteville
Medication Management, Greensboro
Monroe Biomedical Research, Monroe
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07157774

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

NIEHS Clinical Research Unit (CRU), Research Triangle Park

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT01143480

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Novant Health Heart and Vascular Institute, Charlotte
Velocity Clinical Research - Durham, Durham
Moses H Cone Memorial Hospital, Greensboro
እና 7 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ45 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07037433

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

NC Heart and Vascular Research, LLC, Raleigh
Javara Inc. - Wake Forest University Health Sciences, Winston-Salem

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Metrolina Nephrology Associates, PA, Charlotte
Durham Nephrology Associates, PA, Durham
Duke Translational Medicine Institute, Durham
እና 3 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2/3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Research Site, Asheville
Research Site, Chapel Hill
Research Site, Charlotte
እና 11 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Wake Forest University Baptist Medical Center, Winston-Salem

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT06813911

Pelacarsen Roll-over Extension Program

Monroe Biomedical Research, Monroe
Alliance Medical Ministry, Raleigh

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁላይ 2026 · NCT06875973

Pharmacogenomic Informed Statin Prescribing

Durham VA Medical Center, Durham, NC, Durham

ተሳታዮችን በመፈለግ ላይ

እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06568601

Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

Wake Forest University Health Sciences, Winston-Salem

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ27 ፌብሩ 2026 · NCT06488105

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Durham VA Medical Center, Durham, NC, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 4

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ዲሴም 2025 · NCT02915198

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።